Results 171 to 180 of about 4,921,293 (290)

Overcoming Barriers to the Adoption of Decentralized Energy Generation in Central Asia [PDF]

openThe thesis work provides information about possibilities to adopt decentralized generation and what kind of obstacles are preventing the energy change in Central Asia countries.The thesis work provides information about possibilities to adopt ...
RAKHIMOVA, ALIYA
core  

Potential contribution of biomass gasification‐based technology in energy transition: a technical review coupled with bibliometric studies

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Biomass gasification technology has been extensively researched around the world; however, there is a need to evaluate the current research landscape and evolutionary direction of research in the broader context of energy transition. A systematic bibliometric analysis of the Web of Science database was performed for articles that fall within ...
Olasunkanmi Opeoluwa Adeoye, Electo Eduardo Silva Lora, Rubenildo Vieira Andrade, Leonardo Peña Pupo, René Lesme Jaén, Osvaldo José Venturini   +5 more
wiley   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

OracleTrust: A dual-layer provenance-based signature verification scheme for preventing transaction malleability in blockchain. [PDF]

PLoS One
Majeed MR, Zhang P, Raza Z, Alharthi TN, Khan I.   +4 more
europepmc   +1 more source

Decentralized Finance: Users, Applications, and Systems

, 2022
openaire   +2 more sources

New Approaches to Clinical Trials for Rare Diseases: Decentralized Trial Design for Neurofibromatosis Type 1 and Schwannomatosis. [PDF]

Cancers (Basel)
Merker VL, Ahlawat S, Avery RA, Bradford D, Gross AM, Janusz J, Lessing AJ, Manth L, McManus ML, Oberlander B, Pichard DC, Riter W, Sarin KY, Sheard S, Sundby RT, Walsh KS, Wolters PL, Widemann BC, Plotkin SR.   +18 more
europepmc   +1 more source

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola, Aleksandar Gigov, Hubertus G. M. Leufkens, Andrew Bate, Marie Louise De Bruin, Helga Gardarsdottir   +5 more
wiley   +1 more source

A blockchain-enabled scalable and secure architecture for cloud big data storage using sharding and swarming. [PDF]

Sci Rep
Karthika RN, Valliyammai C, UmaRani V, Karthi G.   +3 more
europepmc   +1 more source

Regulatory harmonization: Evolution, globalization and future directions

British Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm, Elaine Y. L. Blair, Christine Y. Lu   +2 more
wiley   +1 more source

Editorial: Pushing boundaries in EHR implementation and innovation through advanced digital health technologies. [PDF]

Front Med (Lausanne)
Piho G, Krastev E, Peltonen LM, Hägglund M, Ross P.   +4 more
europepmc   +1 more source